Download App
PAPER TRADE
Download App
Login
CIPLA
newsbot
Reputation: 198,487 •
Jun 13, 2020 12:38 AM
Why wait for Gilead's antiviral Remdesivir may not end soon?
Indian drug regulator has been reviewing the marketing authorisation applications of Remdesivir of four Indian companies: Cipla, Hetero, Jubilant Life Sciences and BDR Pharmaceuticals
Moneycontrol
https://www.moneycontrol.com/news/coronavirus/why-the-wai...
#CIPLA
#JUBILANT
Vote
Comment
Share
NSE:CIPLA price when posted: 643.95